» Articles » PMID: 14634054

Cell Surface-anchored SR-PSOX/CXC Chemokine Ligand 16 Mediates Firm Adhesion of CXC Chemokine Receptor 6-expressing Cells

Overview
Journal J Leukoc Biol
Date 2003 Nov 25
PMID 14634054
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Direct contacts between dendritic cells (DCs) and T cells or natural killer T (NKT) cells play important roles in primary and secondary immune responses. SR-PSOX/CXC chemokine ligand 16 (CXCL16), which is selectively expressed on DCs and macrophages, is a scavenger receptor for oxidized low-density lipoprotein and also the chemokine ligand for a G protein-coupled receptor CXC chemokine receptor 6 (CXCR6), expressed on activated T cells and NKT cells. SR-PSOX/CXCL16 is the second transmembrane-type chemokine with a chemokine domain fused to a mucin-like stalk, a structure very similar to that of fractalkine (FNK). Here, we demonstrate that SR-PSOX/CXCL16 functions as a cell adhesion molecule for cells expressing CXCR6 in the same manner that FNK functions as a cell adhesion molecule for cells expressing CX(3)C chemokine receptor 1 (CX(3)CR1) without requiring CX(3)CR1-mediated signal transduction or integrin activation. The chemokine domain of SR-PSOX/CXCL16 mediated the adhesion of CXCR6-expressing cells, which was not impaired by treatment with pertussis toxin, a Galphai protein blocker, which inhibited chemotaxis of CXCR6-expressing cells induced by SR-PSOX/CXCL16. Furthermore, the adhesion activity was up-regulated by treatment of SR-PSOX/CXCL16-expressing cells with a metalloprotease inhibitor, which increased surface expression levels of SR-PSOX/CXCL16. Thus, SR-PSOX/CXCL16 is a unique molecule that not only attracts T cells and NKT cells toward DCs but also supports their firm adhesion to DCs.

Citing Articles

infection induces the expression of the chemokine CXCL16 in macrophages to promote chemoattraction of CXCR6 cells.

Leroux L, Chaparro V, Plouffe A, Johnston B, Jaramillo M Infect Immun. 2024; 92(11):e0030924.

PMID: 39436058 PMC: 11556035. DOI: 10.1128/iai.00309-24.


Evolutionary diversity of CXCL16-CXCR6: Convergent substitutions and recurrent gene loss in sauropsids.

Salve B, Sharma S, Vijay N Immunogenetics. 2024; 76(5-6):397-415.

PMID: 39400711 DOI: 10.1007/s00251-024-01357-5.


Pan-cancer mapping of single CD8 T cell profiles reveals a TCF1:CXCR6 axis regulating CD28 co-stimulation and anti-tumor immunity.

Tooley K, Jerby L, Escobar G, Krovi S, Mangani D, Dandekar G Cell Rep Med. 2024; 5(7):101640.

PMID: 38959885 PMC: 11293343. DOI: 10.1016/j.xcrm.2024.101640.


CX3CL1 (Fractalkine)-CX3CR1 Axis in Inflammation-Induced Angiogenesis and Tumorigenesis.

Szukiewicz D Int J Mol Sci. 2024; 25(9).

PMID: 38731899 PMC: 11083509. DOI: 10.3390/ijms25094679.


The CXCL16-CXCR6 axis in glioblastoma modulates T-cell activity in a spatiotemporal context.

Chia T, Billingham L, Boland L, Katz J, Arrieta V, Shireman J Front Immunol. 2024; 14:1331287.

PMID: 38299146 PMC: 10827847. DOI: 10.3389/fimmu.2023.1331287.